Lotus Eye Hospital and Institute Limited inaugurated Lotus Optique, its new optical retail initiative, at the SITRA campus in Coimbatore on August 27, 2026. The launch marks a strategic expansion into the eyewear segment, integrating clinical expertise with consumer retail under one roof.

The event was attended by senior management, including Managing Director Ms. Sangeetha Sundaramoorthy and Director Dr. K.S. Ramalingam. Dr. A.K. Ravikumar, President-Elect of the Tamil Nadu State IMA, served as the Chief Guest, while Dr. S. Karthick Prabhu, Secretary of the Tamil Nadu State IMA, was the Guest of Honour.

Integrating Care and Retail

Lotus Optique aims to bridge the gap between professional eye care and quality eyewear. Located at the company’s facility on Avinashi Road, Civil Aerodrome Post, the store offers a curated selection of branded frames. It leverages the institution’s clinical environment to provide customers with trusted vision solutions alongside fashion-forward choices.

Technology and Fit

The store is equipped with advanced fitting technology to enhance customer experience. Key features include:

• ZEISS VISUFIT 1000: A 3D facial scanning system designed to assist in frame selection and ensure precise fitting.
• Clinical Backing: Access to the company’s established eye care infrastructure and medical expertise.

Management Perspective

Ms. Sundaramoorthy emphasized that the initiative extends the company’s responsibility beyond treating eye conditions to improving overall visual experience. She described Lotus Optique as a natural extension of the brand’s philosophy, aiming to create a space where customers can discover quality eyewear with the reassurance of a trusted institution.

Dr. Ramalingam noted that the move complements the company’s decades-long focus on technology-driven eye care. He stated that the goal is to offer a combination of choice, quality, and trust, positioning Lotus Optique as a convenient destination for families seeking reliable eyewear backed by institutional expertise.

Lotus Eye Hospital reported a 12.6% year-on-year increase in net profit to ₹61.37 lakh for the quarter ended June 30, 2026, driven by a robust 26.2% surge in revenue from operations to ₹1,705.71 lakh. The Coimbatore-based eye care provider’s strong top-line growth signals sustained demand recovery and operational scaling, although rising finance costs and deferred tax expenses moderated bottom-line retention compared to pre-tax profits.

The Board of Directors approved the standalone unaudited financial results at a meeting held on August 10, 2026, pursuant to Regulation 30 and Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The results were reviewed by the Audit Committee and subjected to a limited review by the statutory auditors, Anbarasu & Jalapathi Chartered Accountants. Newspaper advertisements regarding the results were published on August 11, 2026, in Business Standard and The Tamil Hindu.

Financial Performance

Total income rose to ₹1,726.79 lakh from ₹1,370.45 lakh in Q1FY26, supported by increased patient footfall and service utilization. While other income declined slightly to ₹21.08 lakh from ₹18.76 lakh, core operational revenue drove the expansion. Profit before tax improved significantly by 38.4% to ₹101.02 lakh, reflecting better cost management relative to revenue growth. However, net profit growth was tempered by higher tax expenses, which stood at ₹39.65 lakh compared to ₹18.50 lakh in the prior year quarter, including deferred tax expenses.

Expense Breakdown

Operational costs scaled with revenue, with employee benefit expenses rising to ₹364.89 lakh from ₹284.38 lakh, and service expenses increasing to ₹324.82 lakh from ₹261.20 lakh. Finance costs more than quadrupled to ₹50.65 lakh from ₹11.76 lakh, likely due to new borrowings or interest rate adjustments. This increase was partially offset by lower other expenses at ₹232.38 lakh versus ₹239.85 lakh. Depreciation and amortization expenses nearly doubled to ₹163.54 lakh, indicating capital expenditure deployment.

What the Numbers Show

The divergence between the 38.4% rise in pre-tax profits and the 12.6% rise in net profit highlights the impact of tax structuring and deferred tax liabilities on final earnings. While operational efficiency improved—evidenced by total expenses growing at a similar pace to revenue—the significant jump in finance costs suggests increased leverage or debt servicing obligations that warrant monitoring in subsequent quarters. The company’s ability to maintain margin stability despite higher interest outlays demonstrates resilient core operations in the eye care segment.